MDXG
MiMedx GroupDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Composite grade D from latest DB weights. Momentum 18.5 / Value 71.0
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.3.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
18
Value
71
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $9.67
Why
Momentum18 · Δ7d +9.0
Value71 · Δ7d +0.3
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
18
52% active weight
Current posture
7d trendFlat
Δ7d
+9.0
Δ21d
+15.1
Value
71
48% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
+0.4
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 18.5 / Value 71.0
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$531.74M
Beta
1.60
Shares Out
148.1M
P/E (TTM)
23.2
P/S (TTM)
2.38
P/FCF (TTM)
14.03
Rev YoY
+35.3%
EPS YoY
+110.7%
Gross Margin
+82.0%
Op Margin
+13.7%
Net Debt
-$85.59M
Current Ratio
4.41
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology